论文部分内容阅读
目的观察进展性脑梗塞的治疗效果。方法 114例患者随机分为治疗组和对照组,治疗组应用小剂量尿激酶加低分子肝素,对照组不用尿激酶,其他治疗相同,治疗后14d进行疗效评定。结果治疗组在治疗总有效率、神经功能缺损恢复程度明显优于对照组。结论应用小剂量尿激酶能显著提高进展性脑梗塞的治疗效果,提高患者的生存质量。
Objective To observe the therapeutic effect of progressive cerebral infarction. Methods One hundred and fourteen patients were randomly divided into treatment group and control group. In the treatment group, low-dose urokinase and low-molecular-weight heparin were used. In the control group, urokinase was not used. The other treatments were the same. The curative effect was evaluated 14 days after the treatment. Results The total effective rate of treatment group, neurological deficit recovery was significantly better than the control group. Conclusion The application of low-dose urokinase can significantly improve the therapeutic effect of progressive cerebral infarction and improve the quality of life of patients.